BIMI International Medical Inc. Common Stock
BIMI
BIMI was delisted on the 21st of August, 2024.
4 hedge funds and large institutions have $40K invested in BIMI International Medical Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
11% more capital invested
Capital invested by funds: $36K → $40K (+$4K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$11.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.21K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.21K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$151 |
BIMI Hedge Fund Activity: Q2 2017 in Review
4 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in BIMI International Medical Inc. Common Stock (BIMI) for Q2 2017, worth a combined $40K — up 11% from $36K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BIMI positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $11.4K. The largest seller was UBS Group, cutting an estimated $1.21K.
- 4 institutional investors held BIMI International Medical Inc. Common Stock (BIMI) as of Q2 2017, up from 3 in Q1 2017.
- Funds reported $40K of BIMI International Medical Inc. Common Stock stock for Q2 2017, up 11% quarter-over-quarter.
- 1 fund opened new BIMI International Medical Inc. Common Stock positions in Q2 2017 and 0 closed out, a net change of +1 holder.
- The largest BIMI International Medical Inc. Common Stock buyer in Q2 2017 was Virtu KCG Holdings, an estimated $11.4K added.
- The largest BIMI International Medical Inc. Common Stock seller in Q2 2017 was UBS Group, an estimated $1.21K sold.
Based on aggregated 13F filings for Q2 2017.